<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13-vaccines-08-00115">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bonaparte</surname>
    <given-names>M.I.</given-names>
   </name>
   <name>
    <surname>Dimitrov</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Bossart</surname>
    <given-names>K.N.</given-names>
   </name>
   <name>
    <surname>Crameri</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Mungall</surname>
    <given-names>B.A.</given-names>
   </name>
   <name>
    <surname>Bishop</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Choudhry</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Dimitrov</surname>
    <given-names>D.S.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L.F.</given-names>
   </name>
   <name>
    <surname>Eaton</surname>
    <given-names>B.T.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2005</year>
  <volume>102</volume>
  <fpage>10652</fpage>
  <lpage>10657</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.0504887102</pub-id>
  <pub-id pub-id-type="pmid">15998730</pub-id>
 </element-citation>
</ref>
